GlaxoWellcome Harren Jhoti (born 1962[1]) is an Indian-born British structural biologist whose main interest has been rational drug design and discovery.

In 2013, Astex was acquired for around USD $900 million[8] and now operates as a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd, headquartered in Tokyo, Japan.

[11] Jhoti has been published in Nature and Science, and was featured in Time magazine after Astex was named a Technology Pioneer by the World Economic Forum in 2005.

[12] Jhoti was appointed Officer of the Order of the British Empire (OBE) in the 2023 New Year Honours for services to cancer research and drug discovery.

{{cite web}}: CS1 maint: bot: original URL status unknown (link) This article incorporates text available under the CC BY 4.0 license.